Prediction of the pathogens that are the cause of pneumonia by the battlefield hypothesis

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Hirama, Takashi ^a   Yamaguchi, Takefumi ^a   Miyazawa, Hitoshi ^a   Tanaka, Tomoaki ^a   Hashikita, Giichi ^a   Kishi, Etsuko ^a   Tachi, Yoshimi ^a   Takahashi, Shun ^a   Kodama, Keiji ^a   Egashira, Hiroshi ^a   Yokote, Akemi ^a   Kobayashi, Kunihiko ^b   Nagata, Makoto ^a   Ishii, Toshiaki ^c   Nemoto, Manabu ^b   Tanaka, Masahiko ^d   Fukunaga, Koichi ^e   Morita, Satoshi ^f   Kanazawa, Minoru ^a   Hagiwara, Koichi ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

^c Tsurugashima Ikenodai Hospital   (Japan)

^d Kan etsu Hospital   (Japan)

^e Saitama Social Insurance Hospital   (Japan)

^f YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIAL VIRULENCE; BATTLEFIELD HYPOTHESIS; CONTROLLED STUDY; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; HYPOTHESIS; MORAXELLA CATARRHALIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMONIA; PREDICTION; PROSPECTIVE STUDY; PSEUDOMONAS; REAL TIME POLYMERASE CHAIN REACTION; REFERENCE VALUE; SPUTUM ANALYSIS; STREPTOCOCCUS PNEUMONIAE; VALIDATION PROCESS; ADOLESCENT; AGED; BIOLOGICAL MODEL; CELL COUNT; FEMALE; MALE; MICROBIOLOGY; MIDDLE AGED;

HAEMOPHILUS INFLUENZAE; MORAXELLA CATARRHALIS; PSEUDOMONAS; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL COUNT; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PNEUMONIA; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 80052345786     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024474     Document Type: Article

References (28)

1. File TM, (2003) Community-acquired pneumonia. Lancet 362: 1991-2001.
2. Seifert HS, DiRita VJ, (2006) Evolution of Microbial Pathogens: Blackwell Publishing.
3. American Thoracic Society; Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171: 388-416.
4. Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH, (2000) Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis 31: 383-421.
5. Woodhead M, Blasi F, Ewig S, Huchon G, Ieven M, et al. (2005) Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 26: 1138-1180.
6. Masterton RG, Galloway A, French G, Street M, Armstrong J, et al. (2008) Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 62: 5-34.
7. Miyashita N, Matsushima T, Oka M, Japanese Respiratory S, (2006) The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations. Intern Med 45: 419-428.
8. Watanabe A, Yanagihara K, Kohno S, Matsushima T, (2008) Multicenter survey on hospital-acquired pneumonia and the clinical efficacy of first-line antibiotics in Japan. Intern Med 47: 245-254.
9. Calandra T, Cohen J, (2005) The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 33: 1538-1548.
10. Miller DL, Jones R, (1963) A study of techniques for the examination of sputum in a field survey of chronic bronchitis. Am Rev Respir Dis 88: 473-483.
11. French Society of Infectious Diseases (2001) What should the initial antibiotherapy for acute community-acquired pneumonia be? How should it be reassessed in case of failure, given the evolution of responsible pathogens and the resistance of pneumococci? Should combined treatment be used? Med Mal Infect 31: 357-368.
12. Park DR, Sherbin VL, Goodman MS, Pacifico AD, Rubenfeld GD, et al. (2001) The etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness. J Infect Dis 184: 268-277.
13. Miyashita N, Fukano H, Niki Y, Matsushima T, Okimoto N, (2001) Etiology of community-acquired pneumonia requiring hospitalization in Japan. Chest 119: 1295-1296.
14. Luna CM, Famiglietti A, Absi R, Videla AJ, Nogueira FJ, et al. (2000) Community-acquired pneumonia: etiology, epidemiology, and outcome at a teaching hospital in Argentina. Chest 118: 1344-1354.
15. Wattanathum A, Chaoprasong C, Nunthapisud P, Chantaratchada S, Limpairojn N, et al. (2003) Community-acquired pneumonia in southeast Asia: the microbial differences between ambulatory and hospitalized patients. Chest 123: 1512-1519.
16. Ruiz-Gonzalez A, Falguera M, Nogues A, Rubio-Caballero M, (1999) Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia. Am J Med 106: 385-390.
17. Lim WS, Macfarlane JT, Boswell TC, Harrison TG, Rose D, et al. (2001) Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 56: 296-301.
18. Scott JA, Hall AJ, Muyodi C, Lowe B, Ross M, et al. (2000) Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya. Lancet 355: 1225-1230.
19. Soo Hoo GW, Wen YE, Nguyen TV, Goetz MB, (2005) Impact of clinical guidelines in the management of severe hospital-acquired pneumonia. Chest 128: 2778-2787.
20. Leroy O, Jaffre S, D'Escrivan T, Devos P, Georges H, et al. (2003) Hospital-acquired pneumonia: risk factors for antimicrobial-resistant causative pathogens in critically ill patients. Chest 123: 2034-2042.
21. Watanabe A, Fujimura S, Kikuchi T, Gomi K, Fuse K, et al. (2007) Evaluation of dosing designs of carbapenems for severe respiratory infection using Monte Carlo simulation. J Infect Chemother 13: 332-340.
22. Ioanas M, Cavalcanti M, Ferrer M, Valencia M, Agusti C, et al. (2003) Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines. Eur Respir J 22: 876-882.
23. Herer B, Fuhrman C, Demontrond D, Gazevic Z, Housset B, et al. (2001) Diagnosis of nosocomial pneumonia in medical ward: repeatability of the protected specimen brush. Eur Respir J 18: 157-163.
24. Spilker T, Coenye T, Vandamme P, LiPuma JJ, (2004) PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients. J Clin Microbiol 42: 2074-2079.
25. Morozumi M, Nakayama E, Iwata S, Aoki Y, Hasegawa K, et al. (2006) Simultaneous detection of pathogens in clinical samples from patients with community-acquired pneumonia by real-time PCR with pathogen-specific molecular beacon probes. J Clin Microbiol 44: 1440-1446.
26. Templeton KE, Scheltinga SA, Beersma MF, Kroes AC, Claas EC, (2004) Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza a and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3, and 4. J Clin Microbiol 42: 1564-1569.
27. Takahashi T, Nakayama T, (2006) Novel technique of quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA. J Clin Microbiol 44: 1029-1039.
28. Wakefield AE, Pixley FJ, Banerji S, Sinclair K, Miller RF, et al. (1990) Detection of Pneumocystis carinii with DNA amplification. Lancet 336: 451-453.